|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits at other financial institutions | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Certificates of deposit at other financial institutions | ||||||||||||||||||||
| Securities held-to-maturity (fair value of $8,128 and $7,556, respectively) | ||||||||||||||||||||
| Securities available-for-sale, at fair value (amortized cost of $291,317 and $310,097, net of allowance for credit losses of $0 and $0, respectively) | ||||||||||||||||||||
| Securities held-to-maturity, at amortized cost (fair value of $35,183 and $34,396, net of allowance for credit losses of $277 and $277, respectively) | ||||||||||||||||||||
| Loans held for sale, at fair value | ||||||||||||||||||||
| Loans receivable, net of allowance for credit losses of $31,165 and $31,937 (includes loans of $13,159 and $13,183, at fair value, respectively) | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Long-lived assets held for sale | ||||||||||||||||||||
| Operating lease right-of-use (“ROU”) assets | ||||||||||||||||||||
| Federal Home Loan Bank (“FHLB”) stock, at cost | ||||||||||||||||||||
| Other real estate owned (“OREO”) | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Bank owned life insurance (“BOLI”), net | ||||||||||||||||||||
| Mortgage servicing rights (“MSRs”), held at the lower of cost or fair value | ||||||||||||||||||||
| Mortgage Servicing Rights | ||||||||||||||||||||
| Total mortgage servicing rights (“MSRs”), held at the lower of cost or fair value | ||||||||||||||||||||
| MSRs held for sale, held at the lower of cost or fair value | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit intangible, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Noninterest-bearing accounts | ||||||||||||||||||||
| Interest-bearing accounts | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Subordinated notes: | ||||||||||||||||||||
| Principal amount | ||||||||||||||||||||
| Unamortized debt issuance costs | ||||||||||||||||||||
| Total subordinated notes less unamortized debt issuance costs | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Preferred stock, $.01 par value; 5,000,000 shares authorized; none issued or outstanding | ||||||||||||||||||||
| Common stock, $.01 par value; 45,000,000 shares authorized; 7,423,772 and 7,507,519 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...
